BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 20462647)

  • 1. Capping risk adjustment?
    Eugster P; Sennhauser M; Zweifel P
    J Health Econ; 2010 Jul; 29(4):499-507. PubMed ID: 20462647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk adjustment in health insurance and its long-term effectiveness.
    Beck K; Trottmann M; Zweifel P
    J Health Econ; 2010 Jul; 29(4):489-98. PubMed ID: 20434784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal cost reimbursement of health insurers to reduce risk selection.
    Kifmann M; Lorenz N
    Health Econ; 2011 May; 20(5):532-52. PubMed ID: 20572200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing risk selection incentives in health sector reforms.
    Puig-Junoy J
    Int J Health Plann Manage; 1999; 14(4):287-311. PubMed ID: 11184915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new prevention paradox: the trade-off between reducing incentives for risk selection and increasing the incentives for prevention for health insurers.
    Kanters TA; Brouwer WB; van Vliet RC; van Baal PH; Polder JJ
    Soc Sci Med; 2013 Jan; 76(1):150-8. PubMed ID: 23182593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of health care utilization by German sickness fund members--with application to risk adjustment.
    Breyer F; Heineck M; Lorenz N
    Health Econ; 2003 May; 12(5):367-76. PubMed ID: 12720254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk adjustment and risk selection in Europe: 6 years later.
    van de Ven WP; Beck K; Van de Voorde C; Wasem J; Zmora I
    Health Policy; 2007 Oct; 83(2-3):162-79. PubMed ID: 17270311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demand-side strategies to deal with moral hazard in public insurance for long-term care.
    Bakx P; Chernichovsky D; Paolucci F; Schokkaert E; Trottmann M; Wasem J; Schut F
    J Health Serv Res Policy; 2015 Jul; 20(3):170-6. PubMed ID: 25770020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cream-skimming, incentives for efficiency and payment system.
    Barros PP
    J Health Econ; 2003 May; 22(3):419-43. PubMed ID: 12683960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Notes on the planned German health fund model].
    Robra BP; Mayrhofer T
    Gesundheitswesen; 2006 Oct; 68(10):650-2. PubMed ID: 17099827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk selection in the German public health insurance system.
    Nuscheler R; Knaus T
    Health Econ; 2005 Dec; 14(12):1253-71. PubMed ID: 15942977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The case for risk-based premiums in public health insurance.
    Zweifel P; Breuer M
    Health Econ Policy Law; 2006 Apr; 1(Pt 2):171-88. PubMed ID: 18634689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk sharing as a supplement to imperfect capitation: a tradeoff between selection and efficiency.
    van Barneveld EM; Lamers LM; van Vliet RC; van de Ven WP
    J Health Econ; 2001 Mar; 20(2):147-68. PubMed ID: 11252368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How can the regulator show evidence of (no) risk selection in health insurance markets? Conceptual framework and empirical evidence.
    van de Ven WP; van Vliet RC; van Kleef RC
    Eur J Health Econ; 2017 Mar; 18(2):167-180. PubMed ID: 26837411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innovation and risk selection in deregulated social health insurance.
    Lehmann H; Zweifel P
    J Health Econ; 2004 Sep; 23(5):997-1012. PubMed ID: 15353190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Public and private health insurance in Germany: the ignored risk selection problem.
    Grunow M; Nuscheler R
    Health Econ; 2014 Jun; 23(6):670-87. PubMed ID: 23696240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biased selection within the social health insurance market in Colombia.
    Castano R; Zambrano A
    Health Policy; 2006 Dec; 79(2-3):313-24. PubMed ID: 16516333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supplementary health insurance as a tool for risk-selection in mandatory basic health insurance markets.
    Paolucci F; Schut E; Beck K; Gress S; Van de Voorde C; Zmora I
    Health Econ Policy Law; 2007 Apr; 2(Pt 2):173-92. PubMed ID: 18634661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managed competition in the Netherlands-a qualitative study.
    Heinemann S; Leiber S; Gress S
    Health Policy; 2013 Feb; 109(2):113-21. PubMed ID: 23031431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response: Is there a case for risk-based premiums in health care insurance?
    McGuire A
    Health Econ Policy Law; 2006 Apr; 1(Pt 2):189-93; discussion 201-2. PubMed ID: 18634690
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.